Wenzhi Zhang

Dr. Wenzhi Zhang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
XCXi Chen
Xi Chen
Kun ChenKun Chen
Kun Chen
JHJun Hu
Jun Hu
YDYijun Dong
Yijun Dong
MZMenglong Zheng
Menglong Zheng
WZWenzhi Zhang
Wenzhi Zhang
Intervertebral disc degeneration (IDD) is a highly prevalent musculoskeletal disorder affecting millions of adults worldwide, but a poor understanding of its pathogenesis has limited the effectiveness of therapy. In the current study, we integrated untargeted LC/MS metabolomics and magnetic resonance spectroscopy data to investigate metabolic profile alterations during IDD. Combined with validation via a large-cohort analysis, we found excessive lipid droplet accumulation in the nucleus pulposus cells of advanced-stage IDD samples. We also found abnormal palmitic acid (PA) accumulation in IDD nucleus pulposus cells, and PA exposure resulted in lipid droplet accumulation and cell senescence in an endoplasmic reticulum stress-dependent manner. Complementary transcriptome and proteome profiles enabled us to identify solute carrier transporter (SLC) 43A3 involvement in the regulation of the intracellular PA level. SLC43A3 was expressed at low levels and negatively correlated with intracellular lipid content in IDD nucleus pulposus cells. Overexpression of SLC43A3 significantly alleviated PA-induced endoplasmic reticulum stress, lipid droplet accumulation and cell senescence by inhibiting PA uptake. This work provides novel integration analysis-based insight into the metabolic profile alterations in IDD and further reveals new therapeutic targets for IDD treatment.

19 June 2024 in Advanced Science
Verified
Journal Article
Open access
YRYuluo Rong
Yuluo Rong
JWJiaxing Wang
Jiaxing Wang
THTao Hu
Tao Hu
ZSZhongming Shi
Zhongming Shi
CLChuandong Lang
Chuandong Lang
WZWenzhi Zhang
Wenzhi Zhang
Spinal cord injury (SCI) is a severe neurological condition that frequently leads to significant sensory, motor, and autonomic dysfunction. This study sought to delineate the potential mechanistic underpinnings of extracellular vesicles (EVs) derived from ginsenoside Rg1‐pretreated neuronal cells (Rg1‐EVs) in ameliorating SCI. These results demonstrated that treatment with Rg1‐EVs substantially improved motor function in spinal cord‐injured mice. Rg1‐EVs enhance microglial polarization toward the M2 phenotype and repressed oxidative stress, thereby altering immune responses and decreasing inflammatory cytokine secretion. Moreover, Rg1‐EVs substantially diminish reactive oxygen species accumulation and enhanced neural tissue repair by regulating mitochondrial function. Proteomic profiling highlighted a significant enrichment of MYCBP2 in Rg1‐EVs, and functional assays confirmed that MYCBP2 knockdown counteracted the beneficial effects of Rg1‐EVs in vitro and in vivo. Mechanistically, MYCBP2 is implicated in the ubiquitination and degradation of S100A9, thereby promoting microglial M2‐phenotype polarization and reducing oxidative stress. Overall, these findings substantiated the pivotal role of Rg1‐EVs in neuronal protection and functional recovery following SCI through MYCBP2‐mediated ubiquitination of S100A9. This research offers novel mechanistic insights into therapeutic strategies against SCI and supports the clinical potential of Rg1‐EVs.

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
YSYongjin Sun
Yongjin Sun
XLXu Li
Xu Li
XYXiaoxu Yang
Xiaoxu Yang
BCBi Chen
Bi Chen
WZWenzhi Zhang
Wenzhi Zhang
Cellular senescence is a key factor in the development of intervertebral disc degeneration (IVDD). Age‐associated decreases in NAD+ levels play a critical role in regulating cellular senescence. Previous studies have found that small extracellular vesicles (sEVs) secreted by adipocytes (Adipo‐sEVs) or adipose tissue are abundant in nicotinamide phosphoribosyltransferase (NAMPT), which is the key NAD+ biosynthetic enzyme in mammals. Systemic injection of these sEVs significantly improves physical activity and extends the lifespan of aged mice by increasing NAD+ levels. However, to date, the therapeutic potential of Adipo‐sEVs in other age‐associated disease models, such as IVDD, has not been explored. In this study, we investigated the therapeutic effects of Adipo‐sEVs on senescence of nucleus pulposus cells (NPCs) and cartilaginous endplate cells (EPCs). In vitro, Adipo‐sEVs could rejuvenate the senescence of NPCs and EPCs. Age‐related dysfunctions were also ameliorated by Adipo‐sEVs by delivering NAMPT and activating NAD+ biosynthesis and the Sirt1 pathway. Further in vivo experiments revealed that Adipo‐sEV‐mediated delivery of NAMPT attenuated IVDD in rats by rejuvenating senescent NPCs and EPCs. Collectively, the results indicate a new cell‐free tool and provide a promising sEV‐mediated delivery method of NAMPT as a therapeutic approach for IVDD clinically.

4 February 2022 in Cell Biochemistry and Biophysics
Verified
Journal Article
Closed access
PDF file
XWXin-Wen Wang
Xin-Wen Wang
YSYong-Jin Sun
Yong-Jin Sun
XCXiao Chen
Xiao Chen
WZWenzhi Zhang
Wenzhi Zhang

1 March 2022 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
XYXiaoxu Yang
Xiaoxu Yang
YSYongjin Sun
Yongjin Sun
XLXu Li
Xu Li
WZWenzhi Zhang
Wenzhi Zhang
Nucleus pulposus cell (NPC) dysfunction is considered as an important event related to intervertebral disc degeneration (IVDD). In the present study, tandem mass spectrometry (TMT) was used to detect total protein expression of nucleus pulposus (NP) in patients with IVDD and healthy controls. Bioinformatic analysis was performed to identify differentially expressed proteins that may be involved in the degeneration of NP. The results show that Rac1 may be a key protein involved in the degeneration of NP via Wnt/β-catenin pathway activation. We investigated the influence of Rac1 on IVDD degeneration and associated mechanisms. Rac1 expression increased in interleukin (IL)-1β-stimulated human NPCs, consistent with the results of TMT. The Rac1 inhibitor NSC23766 alleviated the degeneration of NPCs in vitro. Furthermore, Rac1 activated Wnt/β-catenin signaling, and the inhibition of this pathway significantly ameliorated the Rac1-mediated degenerative phenotype. NSC23766 exerted protective effects on IVDD in a puncture rat model. Taken together, these data suggest that Rac1 inhibition can delay NPC degeneration, probably through the regulation of the Wnt/β-catenin pathway. This study has the potential to advance understanding of the mechanism of occurrence of degenerative NP tissues and to provide novel strategies for slowing IVDD progression.

1 February 2024 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
THTao Hu
Tao Hu
ZSZhongming Shi
Zhongming Shi
YSYongjin Sun
Yongjin Sun
FHFeng Hu
Feng Hu
YRYuluo Rong
Yuluo Rong
WZWenzhi Zhang
Wenzhi Zhang
Selenophosphate synthetase 1 (SEPHS1) deficiency leads to an increase in reactive oxygen species levels and in the subsequent activation of the Hippo-Yap/Taz signaling pathway. In the rat model of intervertebral disc degeneration (IVDD), overexpression of SEPHS1 and inhibition of Hippo-YAP/Taz mitigated the progression of disc degeneration indicating the involvement of SEPHS1 in IVDD. SEPHS1 is a promising therapeutic target for IVDD.